153 related articles for article (PubMed ID: 38010751)
1. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract][Full Text] [Related]
2. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
Yang Y; Yang Y; Yan S
Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
[TBL] [Abstract][Full Text] [Related]
3. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
[TBL] [Abstract][Full Text] [Related]
4. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
5. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
7. Correlation between lymphoma and second primary malignant tumor.
Liu L; Zhang Q; Chen B
Medicine (Baltimore); 2023 May; 102(19):e33712. PubMed ID: 37171326
[TBL] [Abstract][Full Text] [Related]
8. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
9. Second primary malignancies following thyroid cancer: a population-based study in Taiwan.
Lu CH; Lee KD; Chen PT; Chen CC; Kuan FC; Huang CE; Chen MF; Chen MC
Eur J Endocrinol; 2013 Nov; 169(5):577-85. PubMed ID: 23939917
[TBL] [Abstract][Full Text] [Related]
10. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
11. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
[TBL] [Abstract][Full Text] [Related]
12. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
[TBL] [Abstract][Full Text] [Related]
13. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
[TBL] [Abstract][Full Text] [Related]
14. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
Yang Z; Liu L; Leng K; Shi G
J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
[TBL] [Abstract][Full Text] [Related]
15. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
16. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
17. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
[TBL] [Abstract][Full Text] [Related]
18. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
[TBL] [Abstract][Full Text] [Related]
19. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
Lewinshtein D; Gulati R; Nelson PS; Porter CR
BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
[TBL] [Abstract][Full Text] [Related]
20. Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma.
Jin L; Su X; Li W; Wu J; Zhang H
Sci Rep; 2024 Mar; 14(1):5766. PubMed ID: 38459103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
